OxySure Therapeutics, Inc. - FORM 10-K - EX-23.2 - CONSENT - April 15, 2014

Attached files

file filename
10-K - ANNUAL REPORT - OxySure Therapeutics, Inc.f10k2013_oxysure.htm
EX-10.42(2) - PP AVIATION CORPORATION, TEAMING AGREEMEN - OxySure Therapeutics, Inc.f10k2013ex10xlii2_oxysure.htm
EX-10.1.10 - FIFTH AMENDMENT TO SECOND EMPLOYMENT AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10i10_oxysure.htm
EX-10.3.5 - SINACOLA COMMERCIAL PROPERTIES, LTD. LEASE AMENDMENT, DATED DECEMBER 31, 2013 - OxySure Therapeutics, Inc.f10k2013ex10iii5_oxysure.htm
EX-10.40 - ALPHA CAPITAL ANSTALT ET AL, SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xl_oxysure.htm
EX-10.42 - PP AVIATION CORPORATION, TEAMING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xlii_oxysure.htm
EX-14.1.1 - AS AMENDED CODE OF ETHICS - OxySure Therapeutics, Inc.f10k2013ex14i1_oxysure.htm
EX-31.2 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex31ii_oxysure.htm
EX-10.42(1) - PP AVIATION CORPORATION, TEAMING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xlii1_oxysure.htm
EX-10.1.11 - AS AMENDED SECOND EMPLOYMENT AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10i11_oxysure.htm
EX-31.1 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex31i_oxysure.htm
EX-10.3.6 - SINACOLA COMMERCIAL PROPERTIES, LTD. LETTER AGREEMENT, DATED DECEMBER 31, 2013 - OxySure Therapeutics, Inc.f10k2013ex10iii6_oxysure.htm
EX-10.11.6 - EXTENSION OF THIRD MORATORIUM ON PAYMENT AGREEMENT, - OxySure Therapeutics, Inc.f10k2013ex10xi6_oxysure.htm
EX-10.11.5 - THIRD MORATORIUM ON PAYMENT AGREEMENT, VENCORE SOLUTIONS, LLC DATED AUGUST 2, 2013 - OxySure Therapeutics, Inc.f10k2013ex10xi5_oxysure.htm
EX-10.38 - WALL STREET BUY SELL HOLD CONSULTING AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xxxviii_oxysure.htm
EX-32 - CERTIFICATION - OxySure Therapeutics, Inc.f10k2013ex32_oxysure.htm
EX-10.41 - ALPHA CAPITAL ANSTALT ET AL, FORM OF WARRANT ISSUED PURSUANT TO SECURITIES PURCHASE AGREEMENT - OxySure Therapeutics, Inc.f10k2013ex10xli_oxysure.htm
EX-10.39 - CERTIFICATE OF DESIGNATION OF SERIES B CONVERTIBLE PREFERRED STOCK - OxySure Therapeutics, Inc.f10k2013ex10xxxix_oxysure.htm
Exhibit 23.2
 
We consent to the inclusion in this Annual Report (Form 10-K) of OxySure Systems, Inc. of our report dated April 15, 2014, with respect to its balance sheet as of December 31, 2013 and 2012, and the related statements of operations, stockholders' equity (deficit), and cash flows for the years then ended to be included in this Annual Report.
 
/s/ Sadler Gibb & Associates, LLC
  
Firm’s Manual Signature
  
   
Salt Lake City, UT
  
City, State
  
   
April 15, 2014
  
Date
  

OxySure Therapeutics, Inc. Reports

Also read